News

Read about the progress of individual NINDS PDBP projects and learn about presentations and workshops that are relevant to the PDBP.
Microalbuminuria as a potential biomarker for Parkinson's disease severity: A hypothesis.

  • Meléndez-Flores JD
  • Cavazos-Benítez AC
  • Estrada-Bellmann I
Anosognosia for Memory in Dementia with Lewy Bodies compared with Alzheimer's Disease.

  • Calil V
  • Silveira de Souza A
  • Kenji Sudo F
  • Santiago-Bravo G
  • Assunção N
  • Drummond C
  • Rodrigues F
  • Soares R
  • Oliveira N
  • Teldeschi A
  • Bernardes G
  • Lima G
  • Lima C
  • Lima MA
  • Mattos P
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.

  • Kim C
  • Kwon S
  • Iba M
  • Spencer B
  • Rockenstein E
  • Mante M
  • Adame A
  • Shin SJ
  • Fields JA
  • Rissman RA
  • Lee SJ
  • Masliah E
Cognitive Profile and Markers of AD-Type Pathology in Patients with Lewy Body Dementias.

  • Howard E
  • Irwin DJ
  • Rascovsky K
  • Nevler N
  • Shellikeri S
  • Tropea TF
  • Spindler M
  • Deik A
  • Chen-Plotkin A
  • Siderowf A
  • Dahodwala N
  • Weintraub D
  • Shaw LM
  • Trojanowski JQ
  • Vaishnavi SN
  • Wolk DA
  • Mechanic-Hamilton D
  • Morley JF
  • Duda JE
  • Grossman M
  • Cousins KA
Adaptation and Validation of the Mini-Addenbrooke's Cognitive Examination in Dementia in Arabic Speakers in Egypt.

  • Qassem T
  • Khater MS
  • Emara T
  • Rasheedy D
  • Tawfik HM
  • Mohammedin AS
  • Tolba MF
  • Saber HG
  • Aly El-Gabry D
  • Abdel Aziz K
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.

  • Chia R
  • Sabir MS
  • Bandres-Ciga S
  • Saez-Atienzar S
  • Reynolds RH
  • Gustavsson E
  • Walton RL
  • Ahmed S
  • Viollet C
  • Ding J
  • Makarious MB
  • Diez-Fairen M
  • Portley MK
  • Shah Z
  • Abramzon Y
  • Hernandez DG
  • Blauwendraat C
  • Stone DJ
  • Eicher J
  • Parkkinen L
  • Ansorge O
  • Clark L
  • Honig LS
  • Marder K
  • Lemstra A
  • St George-Hyslop P
  • Londos E
  • Morgan K
  • Lashley T
  • Warner TT
  • Jaunmuktane Z
  • Galasko D
  • Santana I
  • Tienari PJ
  • Myllykangas L
  • Oinas M
  • Cairns NJ
  • Morris JC
  • Halliday GM
  • Van Deerlin VM
  • Trojanowski JQ
  • Grassano M
  • Calvo A
  • Mora G
  • Canosa A
  • Floris G
  • Bohannan RC
  • Brett F
  • Gan-Or Z
  • Geiger JT
  • Moore A
  • May P
  • Krüger R
  • Goldstein DS
  • Lopez G
  • Tayebi N
  • Sidransky E
  • American Genome Center.
  • Norcliffe-Kaufmann L
  • Palma JA
  • Kaufmann H
  • Shakkottai VG
  • Perkins M
  • Newell KL
  • Gasser T
  • Schulte C
  • Landi F
  • Salvi E
  • Cusi D
  • Masliah E
  • Kim RC
  • Caraway CA
  • Monuki ES
  • Brunetti M
  • Dawson TM
  • Rosenthal LS
  • Albert MS
  • Pletnikova O
  • Troncoso JC
  • Flanagan ME
  • Mao Q
  • Bigio EH
  • Rodríguez-Rodríguez E
  • Infante J
  • Lage C
  • González-Aramburu I
  • Sanchez-Juan P
  • Ghetti B
  • Keith J
  • Black SE
  • Masellis M
  • Rogaeva E
  • Duyckaerts C
  • Brice A
  • Lesage S
  • Xiromerisiou G
  • Barrett MJ
  • Tilley BS
  • Gentleman S
  • Logroscino G
  • Serrano GE
  • Beach TG
  • McKeith IG
  • Thomas AJ
  • Attems J
  • Morris CM
  • Palmer L
  • Love S
  • Troakes C
  • Al-Sarraj S
  • Hodges AK
  • Aarsland D
  • Klein G
  • Kaiser SM
  • Woltjer R
  • Pastor P
  • Bekris LM
  • Leverenz JB
  • Besser LM
  • Kuzma A
  • Renton AE
  • Goate A
  • Bennett DA
  • Scherzer CR
  • Morris HR
  • Ferrari R
  • Albani D
  • Pickering-Brown S
  • Faber K
  • Kukull WA
  • Morenas-Rodriguez E
  • Lleó A
  • Fortea J
  • Alcolea D
  • Clarimon J
  • Nalls MA
  • Ferrucci L
  • Resnick SM
  • Tanaka T
  • Foroud TM
  • Graff-Radford NR
  • Wszolek ZK
  • Ferman T
  • Boeve BF
  • Hardy JA
  • Topol EJ
  • Torkamani A
  • Singleton AB
  • Ryten M
  • Dickson DW
  • Chiò A
  • Ross OA
  • Gibbs JR
  • Dalgard CL
  • Traynor BJ
  • Scholz SW
Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson's disease.

  • Singh A
  • Cole RC
  • Espinoza AI
  • Evans A
  • Cao S
  • Cavanagh JF
  • Narayanan NS
Editorial: Prodromal Parkinson's Disease.

  • Crosiers D
  • Santens P
  • Chaudhuri KR
Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia.

  • Murphy N
  • Killen A
  • Gupta RK
  • Graziadio S
  • Rochester L
  • Firbank M
  • Baker MR
  • Allan C
  • Collerton D
  • Taylor JP
  • Urwyler P
[Development of early diagnosis of Parkinson's disease and comprehensive economic analysis of the effect of its implementation].

  • Gusev EI
  • Blokhin VE
  • Vartanov SA
  • Martynov MY
  • Katunina EA
  • Alesenko AV
  • Denisova IA
  • Pavlova EN
  • Polterovich VM
  • Kucheryanu VG
  • Shupik MA
  • Nodel MR
  • Kalinkin AL
  • Sokolov SA
  • Chubarova TV
  • Shakleina MV
  • Pronina TS
  • Ugryumov MV
Repetitive transcranial magnetic stimulation improves Parkinson's freezing of gait via normalizing brain connectivity.

  • Mi TM
  • Garg S
  • Ba F
  • Liu AP
  • Liang PP
  • Gao LL
  • Jia Q
  • Xu EH
  • Li KC
  • Chan P
  • McKeown MJ

Press releases, workshop summaries, and editorials

NINDS Parkinson's Disease Biomarkers Program Consortium Meeting, Bethesda MD (August 12-13, 2019)

The PDBP Annual Consortium Meeting was held August 12-13, 2019 in Rockville, MD.  Principal investigators (PIs), clinical and data management experts from each PDBP project, and representatives from the  NIH, PD nonprofit organizations , and the pharmaceutical industry met to discuss progress over the last twelve months in addition to current and future plans for the program.

Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease

Shared platform to catalyze research collaboration toward biomarker discovery to advance the development disease therapies

AMP PD

The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease. The portal enables researchers to study complex data sets and perform genome-wide analyses at a scale previously impossible.